Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National plan for AIDS for the initial antiretroviral therapy in adult human Immunodeficiency virus (HIV) infected patients in 2012

Antonio Javier Blasco, José Ramón Arribas, Vicente Boix, Bonaventura Clotet, Pere Domingo, Juan González-García, Hernando Knobel, Juan Carlos López, Josep M. Llibre, Fernando Lozano, José M. Miró, Daniel Podzamczer, Juan Miguel Santamaría, Montserrat Tuset, Laura Zamora, Pablo Lázaro, Josep M. Gatell

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National plan for AIDS for the initial antiretroviral therapy in adult human Immunodeficiency virus (HIV) infected patients in 2012'. Together they form a unique fingerprint.

Medicine & Life Sciences